Swedish (OMX) Pharma Industry Analysis
UpdatedFeb 03, 2023
DataAggregated Company Financials
Companies40
- 7D-0.03%
- 3M-4.5%
- 1Y-17.1%
- YTD-1.8%
Last week, the Pharma industry hasn't moved much but Swedencare is up 6.4% in that time. Unfortunately though, the industry is down 17% over the past 12 months. Earnings are forecast to grow by 43% annually.
Industry Valuation and Performance
Has the Swedish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 03 Feb 2023 | kr47.7b | kr7.3b | -kr1,966,129,241.00 | 292.9x | -24.2x | 6.5x |
| Sun, 01 Jan 2023 | kr48.0b | kr7.3b | -kr1,910,765,999.00 | 283.1x | -25.1x | 6.6x |
| Tue, 29 Nov 2022 | kr50.5b | kr7.3b | -kr1,876,545,519.00 | 330.1x | -26.9x | 6.9x |
| Thu, 27 Oct 2022 | kr49.5b | kr7.0b | -kr1,754,469,143.00 | 50x | -28.2x | 7.1x |
| Sat, 24 Sep 2022 | kr48.9b | kr7.0b | -kr1,739,821,936.00 | 47x | -28.1x | 7x |
| Mon, 22 Aug 2022 | kr53.3b | kr6.9b | -kr1,783,375,850.00 | 61.4x | -29.9x | 7.7x |
| Wed, 20 Jul 2022 | kr49.8b | kr6.0b | -kr1,414,388,648.00 | 43.2x | -35.2x | 8.3x |
| Fri, 17 Jun 2022 | kr50.1b | kr5.9b | -kr1,509,116,648.00 | 42.9x | -33.2x | 8.5x |
| Sun, 15 May 2022 | kr47.8b | kr5.6b | -kr1,206,911,761.00 | 42.7x | -39.6x | 8.5x |
| Tue, 12 Apr 2022 | kr55.3b | kr5.5b | -kr1,336,664,342.00 | 39.4x | -41.4x | 10x |
| Thu, 10 Mar 2022 | kr49.5b | kr5.4b | -kr1,389,013,613.00 | 30.2x | -35.7x | 9.1x |
| Sat, 05 Feb 2022 | kr51.9b | kr5.3b | -kr1,043,861,217.00 | 91.7x | -49.8x | 9.8x |
| Mon, 03 Jan 2022 | kr58.5b | kr5.5b | -kr1,100,183,162.00 | 125x | -53.2x | 10.7x |
| Wed, 01 Dec 2021 | kr56.7b | kr5.5b | -kr1,097,623,199.00 | 126.2x | -51.7x | 10.4x |
| Fri, 29 Oct 2021 | kr54.1b | kr4.8b | -kr1,581,672,081.00 | 132.9x | -34.2x | 11.3x |
| Sun, 26 Sep 2021 | kr55.6b | kr4.8b | -kr1,582,367,758.00 | 166.1x | -35.2x | 11.6x |
| Tue, 24 Aug 2021 | kr54.1b | kr4.8b | -kr1,413,242,854.26 | 149.5x | -38.3x | 11.3x |
| Wed, 30 Jun 2021 | kr54.0b | kr4.8b | -kr1,412,039,942.26 | 143.4x | -38.2x | 11.3x |
| Sat, 03 Apr 2021 | kr50.0b | kr4.6b | -kr1,468,409,901.50 | 155.1x | -34.1x | 11x |
| Tue, 05 Jan 2021 | kr48.2b | kr4.5b | -kr1,418,962,725.57 | 135.8x | -34x | 10.8x |
| Fri, 09 Oct 2020 | kr50.1b | kr4.4b | -kr913,043,309.17 | 62.2x | -54.9x | 11.4x |
| Thu, 02 Jul 2020 | kr40.7b | kr4.1b | -kr535,762,892.63 | 19.9x | -76x | 9.9x |
| Sun, 05 Apr 2020 | kr27.3b | kr3.7b | -kr436,185,201.62 | 23.5x | -62.7x | 7.3x |
Price to Earnings Ratio
-83.4x
Current Industry PE
- Investors are pessimistic on the Swedish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 9.7x is higher than the industry's current PS ratio of 6.5x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 30% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Swedish Healthcare industry?
| SE Market | 5.10% | |
| Healthcare | 3.74% | |
| Pharma | -0.033% | |
| Pharma | -0.033% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SECARE Swedencare | kr36.38 | 6.4% +kr346.0m | -65.5% | PE39.3x | |
| RLS RLS Global | kr3.16 | 9.3% +kr21.6m | -36.4% | PS232.6x | |
| KDEV Karolinska Development | kr1.91 | 2.3% +kr11.6m | -53.7% | PS233.3x | |
| ONCOZ OncoZenge | kr6.59 | 15.6% +kr10.4m | -36.0% | PB2x | |
| ERMA Enorama Pharma | kr8.90 | 15.3% +kr9.1m | -50.7% | PS6x |